Genetic variants of Rac1 and NCF2 are identified as susceptibility single nucleotide polymorphisms for IBD. |
The immunosuppressive mechanism of thiopurine treatment relies on the modification of Rac1. |
Rac1 may serve as a potential biomarker to predict (pharmacological) effectiveness of thiopurine therapy. |